Sore throat, runny nose, fatigue at the end of the day: we all know that moment of hesitation in front of the tissue box. Since the start of the school year in September 2026, the circulation of SARS-CoV-2 has been on the rise in several French regions, with the XFG variant in focus.
The problem is that its symptoms closely resemble those of a common cold. So how do we differentiate without succumbing to panic or missing a contagious infection?
XFG Variant and ENT Syndrome: Why the Clinical Picture is Confusing
The XFG variant, nicknamed “Frankenstein” due to its genetic hybridization between the LF.7 and LP.8.1.2 sub-variants of the Omicron variant, continues the trend that has been ongoing for several years: the virus is migrating to the upper respiratory tract. Specifically, we mainly observe acute sore throats, marked nasal congestion, cough, and fatigue.
This is precisely the difficulty. A classic cold produces exactly the same signs. And seasonal flu, which also circulates in the fall, shares this picture. No isolated symptom allows us to assert that we are dealing with Covid rather than another respiratory virus.
Detailed information can be found on Covid 2026 incubation on Pharmidea, particularly regarding the very short time frame between contamination and the appearance of the first signs. With XFG, we are talking about only two to three days, which further complicates the reaction window.
Covid 2026 Symptoms vs Cold: The Clues that Guide the Diagnosis
Since the list of symptoms largely overlaps, we need to think differently. We are not looking for a unique sign, but rather an unusual combination and intensity.
Signals Leaning More Towards Covid
- Disproportionate fatigue compared to other signs: a blocked nose with exhaustion that keeps you in bed for several days is rarely just a cold
- Particularly intense sore throats, described as acute in the clinical observations of the XFG variant, beyond the usual discomfort of a cold
- Aches and fever associated with ENT signs: a cold rarely causes significant fever in adults
- Loss or alteration of taste and smell, a sign more specific to SARS-CoV-2, even though it has become less frequent with recent variants
What Points More Towards a Cold
- Frequent sneezing as the dominant symptom, with a clear and abundant runny nose
- Moderate discomfort that does not prevent daily activities
- Resolution within a few days without deterioration of general condition
One point is emphasized: these clues guide but do not decide. The formal identification of the variant relies on virological analysis and genomic surveillance, not on individual feelings. Some online content presents a “typical” symptomatic profile of XFG as if it were sufficient to make a diagnosis. This is not the case.
Covid Testing in 2026: The Only Reliable Way to Decide
In the face of ambiguous symptoms, testing remains the necessary step. Antigen self-tests sold in pharmacies detect SARS-CoV-2 in a few minutes. Their sensitivity is not perfect, but a positive result removes the doubt.
In the case of a negative test with persistent or worsening symptoms, a PCR test prescribed by a doctor offers superior reliability. It is also the PCR that allows, through sequencing, to identify the circulating variant.
The reflex to adopt: test yourself as soon as unusual respiratory symptoms appear, especially if you have been in contact with a confirmed case in the previous days. With an incubation period as short as that of XFG, things move quickly.
Epidemiological Surveillance in France: What the Field Data Says
The Public Health France bulletin from September 30, 2026, for Île-de-France reported an upward trend in the circulation of SARS-CoV-2 in wastewater, accompanied by an increase in emergency room visits and SOS Médecins calls.
This technical detail has a concrete implication. Wastewater surveillance can signal an epidemic resurgence before consultations visibly increase. In other words, when we start to hear about a “wave” around us, the peak of contamination has often already begun.
The context also varies significantly by region. The WHO indicated, for week 37 of 2026, a generally stable and low positivity rate in most countries, with higher levels in certain areas. In France, the situation is not homogeneous from one region to another, which sometimes makes national recommendations misaligned with local realities.
Practical Steps When Doubt Arises
There is no need to wait for a confirmed diagnosis to act. From the first signs, a few simple reflexes limit transmission, whether it is Covid or another respiratory virus.
Wearing a mask in closed spaces and public transport protects those around you. Ventilating rooms remains an underestimated but effective gesture. Testing quickly allows you to clarify the situation and adjust your behavior with full knowledge of the facts.
For individuals at risk of severe forms (immunocompromised, elderly, those with chronic illnesses), medical consultation should not wait. Antiviral treatments exist, but their effectiveness depends on early administration.
The autumn vaccination campaign remains a preventive lever. Vaccines adapted to recent lineages do not eliminate the risk of infection but significantly reduce the risk of complications. Feedback on perceived effectiveness varies by profile, but pharmacovigilance data continue to support their benefit-risk ratio for vulnerable populations.
Sore throat, blocked nose, fatigue: in the vast majority of cases, it will be a non-serious virus. The difference is that in 2026 we have quick tools to verify. A self-test, a few minutes of patience, and we know what to expect.
